A COVID-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for…
Home »
Regeneron’s Casirivimab and Imdevimab Antibody Cocktail for COVID-19 is First Combination Therapy to Receive FDA Emergency Use Authorization
TARRYTOWN, N.Y., November 21, 2020 – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the antibody cocktail casirivimab and imdevimab administered…
A novel monoclonal antibody therapy cuts LDL cholesterol by half in a high-risk patient population
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol—the so-called “bad” cholesterol—by 50 percent in patients with severe hypercholesterolemia whose…
US allows 1st emergency use of a COVID-19 antibody drug
U.S. health officials have allowed emergency use of the first antibody drug to help the immune system fight COVID-19, an…
New antibody technology for monitoring multiple sclerosis patients may have potential in COVID-19 testing
A new study led by Queen Mary University of London has demonstrated the effectiveness of using a novel light technology…
The promise and uncertainties of antibody testing for coronavirus
As people around the world try to envision recovery from the COVID-19 pandemic, much attention has been paid to antibody…